ALNY - Alnylam Pharmaceuticals Non-GAAP EPS of -$1.39 beats by $0.09 revenue of $335.03M beats by $22.58M February, 23 2023 08:01 AM Alnylam Pharmaceuticals Inc. Alnylam Pharmaceuticals press release ( NASDAQ: ALNY ): Q4 Non-GAAP EPS of -$1.39 beats by $0.09 . Revenue of $335.03M (+29.6% Y/Y) beats by $22.58M . For further details see: Alnylam Pharmaceuticals Non-GAAP EPS of -$1.39 beats by $0.09, revenue of $335.03M beats by $22.58M